Evidence map›Paper›PMID 17409188›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2007

Role for Msh5 in the regulation of Ig class switch recombination.

Hideharu Sekine, Ricardo C Ferreira, Qiang Pan-Hammarström, Robert R Graham, Beth Ziemba, Sandra S de Vries, Jiabin Liu, Keli Hippen, Thearith Koeuth, Ward Ortmann and 18 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 157 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Immunogenetics of Lupus Erythematosus.Advances in experimental medicine and biology · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. TGF-β-mediated enhancement of TScience signaling · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 10 institutions in 4 countries.

Hideharu SekineMedical University of South Carolina, Charleston, SC 29425, USA.
Ricardo C Ferreira
Qiang Pan-Hammarström
Robert R Graham
Beth Ziemba
Sandra S de Vries
Jiabin Liu
Keli Hippen
Thearith Koeuth
Ward Ortmann
Akiko Iwahori
Margaret K Elliott
Steven Offer
Cara Skon
Likun Du
Jill Novitzke
Annette T Lee
Nianxi Zhao
Joshua D Tompkins
David Altshuler
Peter K Gregersen
Charlotte Cunningham-Rundles
Reuben S Harris
Chengtao Her
David L Nelson
Lennart Hammarström
Gary S Gilkeson
Timothy W Behrens
University of Minnesota Medical Center · USMedical University of South Carolina · USKarolinska University Hospital · SEWashington State University · USFeinstein Institute for Medical Research · USMassachusetts Institute of Technology · USIcahn School of Medicine at Mount Sinai · USInstitute of Molecular Biology and Biophysics · RUNational Cancer Institute · USThe Netherlands Cancer Institute · NL

Funding

Systemic Lupus Erythematosus and Ulcerative Colitis StudyU19AI067152 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAMMARSTROM, LENNART · 2005 to 2009
$10.1M
GENE MAPPING IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUSR01AR043274 · NIAMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SIVILS, KATHY L. · 1996 to 2010
$6.5M
NIAID NIH HHS U19 AI 067152NIAID NIH HHS U19 AI067152NIAMS NIH HHS AR 043274NIAMS NIH HHS R01 AR043274
6 · The paper itself

Abstract

Ig class switch recombination (CSR) and somatic hypermutation serve to diversify antibody responses and are orchestrated by the activity of activation-induced cytidine deaminase and many proteins involved in DNA repair and genome surveillance. Msh5, a gene encoded in the central MHC class III region, and its obligate heterodimerization partner Msh4 have a critical role in regulating meiotic homologous recombination and have not been implicated in CSR. Here, we show that MRL/lpr mice carrying a congenic H-2(b/b) MHC interval exhibit several abnormalities regarding CSR, including a profound deficiency of IgG3 in most mice and long microhomologies at Ig switch (S) joints. We found that Msh5 is expressed at low levels on the H-2(b) haplotype and, importantly, a similar long S joint microhomology phenotype was observed in both Msh5 and Msh4-null mice. We also present evidence that genetic variation in MSH5 is associated with IgA deficiency and common variable immune deficiency (CVID) in humans. One of the human MSH5 alleles identified contains two nonsynonymous polymorphisms, and the variant protein encoded by this allele shows impaired binding to MSH4. Similar to the mice, Ig S joints from CVID and IgA deficiency patients carrying disease-associated MSH5 alleles show increased donor/acceptor microhomology, involving pentameric DNA repeat sequences and lower mutation rates than controls. Our findings suggest that Msh4/5 heterodimers contribute to CSR and support a model whereby Msh4/5 promotes the resolution of DNA breaks with low or no terminal microhomology by a classical nonhomologous end-joining mechanism while possibly suppressing an alternative microhomology-mediated pathway.

Indexed as

AllelesAnimalsB-LymphocytesCell Cycle ProteinsCommon Variable ImmunodeficiencyDisease SusceptibilityDNA-Binding ProteinsGene Expression RegulationHaplotypesHumansIgA DeficiencyImmunoglobulin Class SwitchingImmunoglobulin GMiceMice, CongenicMice, Inbred MRL lprCell Cycle ProteinsDNA-Binding ProteinsImmunoglobulin GMSH5 protein, humanMsh5 protein, mouseRNA, Messenger

Identifiers

PMID17409188
PMCPMC1855370
OpenAlexW2074880195

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.